Despite the fact that hard, laboratories need to do their ideal to maintain an updated listing of related DBZDs of their MS confirmation assays and consider whether or not these DBZDs are going to be detected on their own distinct immunoassay platforms.A comprehensive overview was completed by utilizing the EMCDDA/EDND database on a regular basis m